News

Zealand Pharma Reports Successful Year with Significant Growth

Zealand Pharma Reports Successful Year with Significant Growth

Zealand Pharma Reports Significant Financial Results for 2024

Company announcement No. 2 / 2025 introduces the impressive achievements of Zealand Pharma A/S, a biotechnology company concentrated on the innovation of peptide-based medications.

With a dynamic year behind it, Zealand Pharma has made substantial advancements in its differentiated obesity pipeline, laying the groundwork for sustained growth in the upcoming years. As key progress is made in this critical area, the company looks ahead with optimism.

Transformative Achievements in Obesity Drug Development

In 2024, Zealand Pharma celebrated significant clinical advancements within its mid- to late-stage obesity programs. The company highlights positive results from several trials, setting the stage for future endeavors. “This past year has been a turning point for Zealand Pharma, especially as we gathered encouraging data across our clinical trials, while also securing substantial funding for our research initiatives,” emphasized Adam Steensberg, President and Chief Executive Officer.

Key Clinical Trials Show Promising Results

Among the standout achievements are:

  • Long-acting amylin analog petrelintide showed positive results in a 16-week Phase 1b trial, paving the way for a broader Phase 2b trial aimed at individuals with overweight or obesity.
  • Dapiglutide, a dual GLP-1/GLP-2 receptor agonist, demonstrated encouraging topline results in a 13-week Phase 1b trial, leading to an expansion of this trial to explore higher doses.
  • Survodutide, another dual agonist, advanced into a significant Phase 3 clinical program focused on the treatment of MASH, further cementing Zealand Pharma's commitment to addressing complex obesity issues.

Robust Financial Performance

Zealand Pharma’s financial results for 2024 have also reflected a robust commitment to growth:

  • Secured an impressive DKK 8.5 billion (approximately USD 1.2 billion) through equity raises, illustrating strong investor confidence.
  • Despite net operating expenses climbing to DKK -1,327 million, the company's strategic investments in R&D show promise for long-term success.
  • The cash position significantly improved to DKK 9,022 million from DKK 1,633 million in the previous year, providing a stable foundation for upcoming clinical trials and research expenditures.

Looking Ahead: Financial Guidance for 2025

Zealand Pharma is gearing up for an exciting 2025. The company anticipates embarking on several large Phase 2b trials, laying the groundwork for its wholly-owned obesity programs. Financial guidance suggests a net operating expenses range between DKK 2,000 – 2,500 million, primarily driven by research investments focused on innovative peptide therapeutics related to obesity.

Continued Development in Obesity Treatments

The pipeline for obesity treatments remains promising with the planned initiation of:

  • A major Phase 2b trial for petrelintide, aimed at broadening this medication's application among individuals with obesity and type 2 diabetes.
  • Further trials for dapiglutide, ensuring it is positioned for optimum results as higher doses are explored.
  • Ongoing research for survodutide, where partnerships with Boehringer Ingelheim continue to enhance the scope of potential treatments available for patients.

Expanding into Rare Diseases and Chronic Inflammation

Besides the focus on obesity, Zealand Pharma shows commitment to advancing therapies for rare diseases, such as congenital hyperinsulinism (CHI) and short bowel syndrome (SBS). By addressing these serious health concerns, Zealand Pharma demonstrates its dedication to improving patient outcomes across different therapeutic areas.

Ongoing Commitment to Sustainability

In 2024, Zealand Pharma put a refined sustainability strategy into action, emphasizing environmental responsibility and strategic growth. Moving forward, the company plans to further strengthen its sustainability initiatives while achieving a notable increase in employee engagement and decreasing turnover rates, showcasing its commitment to not only patients but also to its workforce.

Join Zealand Pharma's Upcoming Conference Call

Zealand Pharma invites stakeholders to join its conference call to discuss the financial results and strategic plans outlined for the coming year. Key executives will be present to share insights into the clinical advancements and business operations that drive future success.

Frequently Asked Questions

What were Zealand Pharma's significant achievements in 2024?

In 2024, Zealand Pharma successfully advanced drugs in its obesity pipeline and raised substantial funding for ongoing research and development.

How did the company's financial position change in 2024?

The cash position improved dramatically to DKK 9,022 million from DKK 1,633 million, allowing for increased investment in R&D.

What trials are Zealand Pharma launching in 2025?

Zealand Pharma plans to launch multiple Phase 2b trials focusing on its obesity pipeline, including studies involving petrelintide and dapiglutide.

How does Zealand Pharma integrate sustainability into its strategy?

The company has launched a refined sustainability strategy, focusing on climate change mitigation and continued employee engagement.

Where can I find more information about Zealand Pharma?

For further details about Zealand Pharma's operations and drug candidates, visit their official website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Insight Into Midland TX Real Estate Sales Timing

Updated Category News Views 7

How Fast Do Homes Move in Midland? This ain't my first rodeo predicting the real estate rollercoaster in Texas. Midland's housing market is one nifty beast—homes can either sell like hotcakes or just sit gathering dust. You got HelloNation pulling in DeLaura Gammage, a pro who knows the terrain like the back of her hand, to spell out the why and how long it'll take to...

Continue Reading
Tips for a Dementia-Friendly Thanksgiving Gathering

Updated Category News Views 36

Thanksgiving's supposed to bring families round the table, right? But toss a few knuckleheads together, add a pinch of dementia, and suddenly it's like throwing dice at a craps table. The American Speech-Language-Hearing Association (ASHA) reckons they've got tricks up their sleeve to keep the holiday from unraveling. The Thanksgiving Reality Check The hustle, bustle, and...

Continue Reading
Galileo's Robot Dog Takes Charge in Polish Warehouses

Updated Category News Views 146

Robotic Innovation Makes Waves in Europe You ever think you’d see the day when a dog—albeit a robotic one—takes the night shift at a warehouse? Well, here we are. Galileo Robotics has unleashed its C1-W robot dog in Poznan, Poland, and it's more than just a fancy tech gimmick. This thing's got potential, bridging gaps left wide open by human labor shortages and...

Continue Reading
YYForce's Strategic Play: Robotics and AI Expansion

Updated Category News Views 28

Innovation Meets Pragmatism at YYForce There's a new bout of excitement brewing over at YYForce Inc. (NASDAQ: YFOR), if the latest announcements are anything to go by. The Singapore-based AI-enabled workforce dynamo is laying out priorities like a general plotting a campaign—pragmatic, strategic, and with a keen eye on the bottom line. Aiming for a Technological Edge In...

Continue Reading
Orangetheory Adds NASM Training for Coaching Edge

Updated Category News Views 36

A Shift in Coaching Standards Ever seen a fitness brand tilt towards a change so fast it leaves you slack-jawed? Well, here we go with Orangetheory Fitness pushing its chips all in with NASM-certified coaches geared for the GLP-1 era. A bold move? Sure, but they aim to become trendsetters instead of just another player in the fitness game. The Impact of NASM Certification...

Continue Reading
Sasol AGM Resolutions Passed in One Swift Swing

Updated Category News Views 102

Sasol's AGM Delivers Smooth Sailing for Shareholders Can't say I'm surprised, but Sasol's annual general meeting on the 13th of November went off without a hitch—unless, of course, you're one of those folks who just loves fireworks at these gatherings. The entire set of resolutions danced through with a resounding "Aye," making it one heck of a day for anyone banking on...

Continue Reading
Mall of America Strives for World Record This Black Friday

Updated Category News Views 111

History in the Making at Mall of America Yeah, it seems these folks are not just about shopping anymore. The Mall of America is aiming to set the bar high this Black Friday, eyeing a GUINNESS WORLD RECORDS title for the most people holding up the same shopping bag all at once. Imagine a thousand people, synchronized like a flash mob—only with shopping bags instead of...

Continue Reading
SahajMobile's $25M Boost: Impact on Bangladesh Market

Updated Category News Views 42

Untapped Digital Frontier in Bangladesh There's an undeniable buzz around SahajMobile's recent $25 million credit facility, and it's one worth dissecting. This shot of capital, lined up with ALMA as part of SahajMobile’s Series A gamble, is setting the stage for a real shuffle in Bangladesh's digital landscape. Plugging into a Market Gap Ever since it hit the ground...

Continue Reading
Lululemon Faces Class Action over Alleged Missteps

Updated Category News Views 13

Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 319

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading

Top 5 Most Recently Viewed Articles

Global Smart Waste Management Market Growth Insights

Updated Category News Views 124

Overview of the Smart Waste Management Market In recent years, the smart waste management market has garnered substantial attention, projected to transition from $2.2 billion in valuation to an impressive $8.3 billion. This surge reflects a remarkable compound annual growth rate (CAGR) of 15.6% from 2024 to 2032. The driving force behind this growth stems from increasing...

Continue Reading
Exploring the Collaborative Spirit at the China-US Event

Updated Category News Views 150

Celebrating Cultural Connections The recent 'My China Album' event highlighted the importance of cultural exchanges between the United States and China, focusing on the shared journeys and experiences of citizens from both nations. Strengthening Relations through Understanding During this special occasion, the ambassador emphasized the collaborative spirit that can propel...

Continue Reading
Exciting New Active Adult Community Launches in Central Oregon

Updated Category News Views 143

Welcoming Active Adults to Dry Canyon Introducing Dry Canyon, an extraordinary gated community designed specifically for those aged 55 and better. This remarkable development offers active adults a perfect blend of resort-style living and scenic beauty, all nestled in the heart of Central Oregon. As part of this celebration, Lennar, a well-respected name among...

Continue Reading
XTI Aerospace Announces Upcoming Town Hall for Stakeholders

Updated Category News Views 153

XTI Aerospace Invites Stakeholders to Upcoming Town Hall Updates on Tri-Fan 600, Valkyrie AI and Vanguard Platform ENGLEWOOD, Colo. – XTI Aerospace, Inc. (NASDAQ: XTIA) is at the forefront of advancing vertical flight technologies. The company is making exciting progress with its next-generation vertical takeoff and landing (VTOL) aircraft, the TriFan 600. XTI Aerospace...

Continue Reading
Big Lots Launches Discounts and Donations for Vets in November

Updated Category News Views 47

Big Lots Supports Veterans and Active Military with November Campaigns Every November, Big Lots makes a concerted effort to give back to veterans and active military members. This initiative is a part of their commitment to recognizing the sacrifices made by those who serve our country. Highlighting their respect for military service, Big Lots introduces various discounts...

Continue Reading